Literature DB >> 14743216

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway.

Tewis Bouwmeester1, Angela Bauch, Heinz Ruffner, Pierre-Olivier Angrand, Giovanna Bergamini, Karen Croughton, Cristina Cruciat, Dirk Eberhard, Julien Gagneur, Sonja Ghidelli, Carsten Hopf, Bettina Huhse, Raffaella Mangano, Anne-Marie Michon, Markus Schirle, Judith Schlegl, Markus Schwab, Martin A Stein, Andreas Bauer, Georg Casari, Gerard Drewes, Anne-Claude Gavin, David B Jackson, Gerard Joberty, Gitte Neubauer, Jens Rick, Bernhard Kuster, Giulio Superti-Furga.   

Abstract

Signal transduction pathways are modular composites of functionally interdependent sets of proteins that act in a coordinated fashion to transform environmental information into a phenotypic response. The pro-inflammatory cytokine tumour necrosis factor (TNF)-alpha triggers a signalling cascade, converging on the activation of the transcription factor NF-kappa B, which forms the basis for numerous physiological and pathological processes. Here we report the mapping of a protein interaction network around 32 known and candidate TNF-alpha/NF-kappa B pathway components by using an integrated approach comprising tandem affinity purification, liquid-chromatography tandem mass spectrometry, network analysis and directed functional perturbation studies using RNA interference. We identified 221 molecular associations and 80 previously unknown interactors, including 10 new functional modulators of the pathway. This systems approach provides significant insight into the logic of the TNF-alpha/NF-kappa B pathway and is generally applicable to other pathways relevant to human disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14743216     DOI: 10.1038/ncb1086

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  360 in total

1.  TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation.

Authors:  Tiziana Zotti; Antonio Uva; Angela Ferravante; Mariangela Vessichelli; Ivan Scudiero; Michele Ceccarelli; Pasquale Vito; Romania Stilo
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Charting gene regulatory networks: strategies, challenges and perspectives.

Authors:  Gong-Hong Wei; De-Pei Liu; Chih-Chuan Liang
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

3.  Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases.

Authors:  Ziyou Cui; Shannamar Dewey; Aldrin V Gomes
Journal:  Am J Cardiovasc Dis       Date:  2011-09-10

Review 4.  Tools used to study how protein complexes are assembled in signaling cascades.

Authors:  Susan Dwane; Patrick A Kiely
Journal:  Bioeng Bugs       Date:  2011-09-01

Review 5.  New insights into the biogenesis of nuclear RNA polymerases?

Authors:  Philippe Cloutier; Benoit Coulombe
Journal:  Biochem Cell Biol       Date:  2010-04       Impact factor: 3.626

Review 6.  Profiling of protein interaction networks of protein complexes using affinity purification and quantitative mass spectrometry.

Authors:  Robyn M Kaake; Xiaorong Wang; Lan Huang
Journal:  Mol Cell Proteomics       Date:  2010-05-05       Impact factor: 5.911

Review 7.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 8.  Versatile TPR domains accommodate different modes of target protein recognition and function.

Authors:  Rudi Kenneth Allan; Thomas Ratajczak
Journal:  Cell Stress Chaperones       Date:  2010-12-09       Impact factor: 3.667

Review 9.  Systems biology in immunology: a computational modeling perspective.

Authors:  Ronald N Germain; Martin Meier-Schellersheim; Aleksandra Nita-Lazar; Iain D C Fraser
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

10.  Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.

Authors:  Marzenna Blonska; Yun You; Romas Geleziunas; Xin Lin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.